麒麟集團(08109.HK)接獲判決需向原告支付950萬元判決款項
麒麟集團控股(08109.HK)公佈,於6月22日,接獲判決,內容有關原告就公司發行的本金額爲950萬元及年利率爲8%應計的逾期債券對公司提起的民事訴訟。根據判決,高等法院原訟法庭命令公司向原告支付判決款項950萬元連同應計利息及法律費用8.5萬元。
公司指,董事並無知悉業務營運及財務狀況因訴訟造成的任何重大影響,將就判決總額的可能還款時間表與原告取得聯絡。
另外,就個人肖衛針對公司8名現任董事、6名前任董事及2名前任公司祕書、公司及其他人士提起多項衍生訴訟,公司及董事會斷然否認所有指控,正考慮申請撤銷衍生訴訟,惟待獲取獨立法律意見。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.